Trimetazidine

CAS: 5011-34-7

Ref. 3D-FAA01134

Produktinformation

• Name: Trimetazidine
• Synonyme: 1-(2,3,4-Trimethoxybenzyl)Piperazine, 1-[(2,3,4-Trimethoxyphenyl)methyl]piperazine, 4-(2,3,4-Trimethoxybenzyl)piperazine, Piperazine, 1-(2,3,4-trimethoxybenzyl)-, Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, Preductal, Preductal MB, Trimetazidine ( base and/or unspecified salts), Trimetazidine (TMZ), Vasorel

Beschreibung

Trimetazidine is a potent anti-ischemic and anti-anginal agent that has been shown to inhibit apoptosis in human cell lines. It acts as a kinase inhibitor, modulating the activity of various enzymes involved in cell cycle regulation and protein synthesis. Trimetazidine has been found to be an effective analog for the treatment of tumors, acting as an inhibitor of tumor cell growth and inducing apoptosis in cancer cells. Additionally, it has been shown to reduce the risk of urinary tract infections in patients undergoing chemotherapy. Overall, Trimetazidine is a promising anticancer agent with potential therapeutic applications.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 266.34 g/mol
• Formel: C₁₄H₂₂N₂O₃
• Reinheit: Min. 95%